Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhirou Xu

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|May 1, 2026
Pemphigoid associated with quinolone antibiotics: a real-world pharmacovigilance study of the FDA adverse event reporting system and literature-based evidenceXin Li, Danna Zhang, Jiangxin Xu, et al.
Infection and Drug Resistance|June 27, 2024
Therapeutic Drug Monitoring of Linezolid in Drug-Resistant Tuberculosis Patients: Clinical Factors and Hematological ToxicitiesJunjie Cheng, Yuan Yuan, Jinmeng Li, et al.
Journal of Neuroinflammation|June 10, 2021
Early glycolytic reprogramming controls microglial inflammatory activationJunjie Cheng, Rong Zhang, Zhirou Xu, et al.
International Immunopharmacology|April 21, 2026
Vitamin K3 alleviates brain injury and behavioral deficits by inhibiting neuroinflammation in intracerebral hemorrhage in vitro and in vivoZhirou Xu, Kexin Chen, Jiawei Ouyang, et al.
Cell Reports|October 9, 2024
Polo-like kinase 2 promotes microglial activation via regulation of the HSP90α/IKKβ pathwayJunjie Cheng, Lei Wu, Xiaowan Chen, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|May 1, 2026
Pemphigoid associated with quinolone antibiotics: a real-world pharmacovigilance study of the FDA adverse event reporting system and literature-based evidenceXin Li, Danna Zhang, Jiangxin Xu, et al.
Infection and Drug Resistance|June 27, 2024
Therapeutic Drug Monitoring of Linezolid in Drug-Resistant Tuberculosis Patients: Clinical Factors and Hematological ToxicitiesJunjie Cheng, Yuan Yuan, Jinmeng Li, et al.
Journal of Neuroinflammation|June 10, 2021
Early glycolytic reprogramming controls microglial inflammatory activationJunjie Cheng, Rong Zhang, Zhirou Xu, et al.
International Immunopharmacology|April 21, 2026
Vitamin K3 alleviates brain injury and behavioral deficits by inhibiting neuroinflammation in intracerebral hemorrhage in vitro and in vivoZhirou Xu, Kexin Chen, Jiawei Ouyang, et al.
Cell Reports|October 9, 2024
Polo-like kinase 2 promotes microglial activation via regulation of the HSP90α/IKKβ pathwayJunjie Cheng, Lei Wu, Xiaowan Chen, et al.
Pageof 1